Bittner, Beate

Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities

Bittner, B., Richter, W., & Schmidt, J. (2018) · BioDrugs

Biosimilars and Bioanalytical MethodsIntramuscular injections and effects

Cited by 447

Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 study

Davies, A., Merli, F., Mihaljevic, B., Siritanaratkul, N., Solal-Céligny, P., Barrett, M., Berge, C., Bittner, B., Boehnke, A., McIntyre, C., et al. (2014) · The Lancet Oncology

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research

Cited by 114

Non-Clinical Pharmacokinetic/Pharmacodynamic and Early Clinical Studies Supporting Development of a Novel Subcutaneous Formulation for the Monoclonal Antibody Rituximab

Bittner, B., Richter, W., Hourcade-Potelleret, F., Herting, F., & Schmidt, J. (2014) · Drug Research

Lymphoma Diagnosis and TreatmentMonoclonal and Polyclonal Antibodies Research

Cited by 32

Use of a Population Pharmacokinetic Approach for the Clinical Development of a Fixed‐Dose Subcutaneous Formulation of Trastuzumab

Hourcade‐Potelleret, F., Lemenuel‐Diot, A., McIntyre, C., Brewster, M., Lum, B., & Bittner, B. (2014) · CPT: Pharmacometrics & Systems Pharmacology

Pharmaceutical studies and practicesHER2/EGFR in Cancer Research

Cited by 28

Pharmacokinetics and pharmacodynamics of single subcutaneous doses of tocilizumab administered with or without rHuPH20

Morcos, P. N., Zhang, X., McIntyre, C., Bittner, B., Rowell, L., & Hussain, Z. (2013) · Int. Journal of Clinical Pharmacology and Therapeutics

Rheumatoid Arthritis Research and TherapiesBiosimilars and Bioanalytical Methods

Cited by 23